{"disease":{"id":"critical-covid-19-with-respiratory-failure","name":"critical covid 19 with respiratory failure"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04311697","title":"Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"APR Applied Pharma Research s.a.","has_results":true},{"nct_id":"NCT04453839","title":"ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"APR Applied Pharma Research s.a.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}